Get more replies from employers
Send a job-specific resume in minutes.
Convatec is seeking a Lead Microbiologist to act as Site Microbiology Expert for Deeside and Rhymney sites, providing technical leadership for microbiology and sterilisation activities in a regulated manufacturing environment.
You will lead a small laboratory team and ensure compliance with regulatory, quality, and procedural requirements, overseeing sterilisation validation for terminally sterilised products.
The Lead Microbiologist acts as the Site Microbiology Expert for the Deeside and Rhymney sites, providing technical leadership for microbiology and sterilisation activities. The role is responsible for leading a small laboratory team, ensuring compliance with regulatory, quality, and procedural requirements, and overseeing sterilisation validation test methods for terminally sterilised products manufactured at the Deeside site. The position supports continuous improvement, maintains compliance within controlled environments, and champions ConvaTec's mission, values, and quality standards.
Convatec provides equal employment opportunities for all current employees and applicants for employment. This policy means that no one will be discriminated against because of race, religion, creed, color, national origin, nationality, citizenship, ancestry, sex, age, marital status, physical or mental disability, affectional or sexual orientation, gender identity, military or veteran status, genetic predisposing characteristics or any other basis prohibited by law.
Convatec is a global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care. With over 10,000 colleagues, we provide products and services in around 90 countries, united by a promise to be forever caring. Our solutions provide a range of benefits, from infection prevention, treatment for hard to heal wounds, at-risk skin and ulcerated tissue to supporting debilitating conditions, improved patient outcomes and reduced care costs. Convatec's revenues in 2025 were over $2 billion. The company is a constituent of the FTSE 100 Index (LSE:CTEC). To learn more please visit: http://www.convatecgroup.com.